Table 1 Population characteristics
Parameters | N° of newborns | % | Parameters | N° of newborns | % |
|---|---|---|---|---|---|
GA (weeks) | RDS | 384 | 99.7% | ||
22–23 - 24 | 92 | 22.6% | PDA | 251 | 65.0% |
25 | 102 | 24.2% | IVH | 167 | 43.5% |
26 | 134 | 31.8% | LPV | 99 | 26.7% |
≥ 27 | 90 | 21.4% | Fungal Sepsis | 46 | 11.4% |
Bacterial Sepsis | 178 | 44.2% | |||
BW (g) | BPD | 208 | 54.9% | ||
300–450 | 9 | 2.1% | Blood transfusions | 357 | 89.9% |
451–600 | 70 | 16.6% | EPO therapy | 210 | 55.6% |
601–750 | 167 | 39.7% | Mechanical ventilation ( > 7 days) | 258 | 69.2% |
> 750 | 175 | 41.6% | NPT ( > 7 days) | 303 | 80.6% |
Male | 182 | 45.5% | ROP | 265 | 62.9% |
Inborn | 358 | 88.0% | P - ROP | 102 | 24.2% |
APGAR score 5th minute ≤ 7 | 176 | 47.7% | Preplus disease | 55 | 13.1% |
PROM | 122 | 31.9% | Plus disease | 79 | 18.8% |
Chorioamnionitis | 93 | 27.8% | Laser treatment | 89 | 21.1% |
Antenatal steroids | 331 | 84.0% | Adverse outcome | 14 | 3.3% |